Lumos Diagnostics Holdings Limited (LDXHF)
OTCMKTS · Delayed Price · Currency is USD
0.0858
+0.0358 (71.60%)
Jul 31, 2025, 2:09 PM EDT
LDXHF Market Cap
LDXHF has a market cap or net worth of $39.13 million as of August 1, 2025. Its market cap has increased by 172.59% in one year.
Market Cap
39.13M
Enterprise Value
41.50M
Revenue
14.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since July 5, 2021, LDXHF's market cap has decreased from 148.12M to 39.13M, a decrease of -73.58%. That is a compound annual growth rate of -27.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 38.99M | 140.48% |
| Dec 31, 2024 | 16.21M | -32.31% |
| Dec 29, 2023 | 23.95M | 249.55% |
| Dec 30, 2022 | 6.85M | -93.71% |
| Dec 31, 2021 | 108.92M | -26.46% |
| Jul 5, 2021 | 148.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |